This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 4719 results found since Jan 2013.
Delayed-Release ADHD Therapy Slightly Mitigates Slowed Growth in Kids
(MedPage Today) -- NASHVILLE -- Youth with attention-deficit/hyperactivity disorder (ADHD) saw mildly different growth trajectories with certain popular medications, researchers reported.
Compared with youth prescribed lisdexamfetamine dimesylate...
Source: MedPage Today Neurology - September 10, 2023 Category: Neurology Source Type: news
ADHD linked to higher risk of mental health disorders
Major depression, PTSD, anorexia nervosa, and suicide attempts were all linked to ADHD.
Source: PsycPORT.com - September 8, 2023 Category: Psychiatry Source Type: news
ADHD Is Independent Risk Factor for Psychiatric Disorders
THURSDAY, Sept. 7, 2023 -- Attention-deficit hyperactivity disorder (ADHD) is an independent risk factor for certain psychiatric disorders, including anorexia nervosa and major depressive disorder, according to a study published online Sept. 5 in...
Source: Drugs.com - Pharma News - September 7, 2023 Category: Pharmaceuticals Source Type: news
Increased anxiety and depression among collegiate athletes with comorbid ADHD and history of concussion - Moore RD, Kay JJM, Gunn B, Harrison AT, Torres-McGehee T, Pontifex MB.
BACKGROUND: Attention Deficit Hyperactivity Disorder (ADHD) is prevalent among student-athletes when compared to the general population. Mental health disruptions (i.e., depression or anxiety) are common among student-athletes, and risk of experiencing dep...
Source: SafetyLit - September 6, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
---
Heading into her first year of college, Clara Pitts has an added level of stress as her ADHD medications continue to be in short supply.
Source: CNN.com - Health - September 5, 2023 Category: Consumer Health News Source Type: news
ADHD: What Parents Need to Know
MONDAY, Sept. 4, 2023 -- Lots of children and adolescents have the condition known as ADHD, or attention-deficit/hyperactivity disorder.
What should parents know? A number of treatments exist to help with functioning, including medications approved...
Source: Drugs.com - Daily MedNews - September 4, 2023 Category: General Medicine Source Type: news
Generic Drugmakers Start Shipping Copies of ADHD Drug Generic Drugmakers Start Shipping Copies of ADHD Drug
Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical ' s drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD medicine in the United States.Reuters Health Information
Source: Medscape Medical News Headlines - September 1, 2023 Category: Consumer Health News Tags: Psychiatry News Source Type: news
ADHD drug Ritalin could wean America's 5million cocaine users off the powder, study suggests
Researchers at the University of Virginia say animal studies have shown Ritalin (pictured) triggers reduced dependence on the white powder, although results are mixed in humans.
Source: the Mail online | Health - August 31, 2023 Category: Consumer Health News Source Type: news
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
DUBLIN, Aug. 31, 2023 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that its Specialty Generics segment, operating as SpecGx LLC, received approval on August 25, ... Biopharmaceuticals, Generics, FDA Mallinckrodt, SpecGx, lisdexamfetamine, ADHD
Source: HSMN NewsFeed - August 31, 2023 Category: Pharmaceuticals Source Type: news
Systematic review of environmental and psychosocial risk factors associated with attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder in children and adolescents - Elbagir R, Faisal M, O'Hanharan S.
BACKGROUND: In the majority of cases, attention deficit hyperactivity disorder (ADHD) is accompanied by one or more comorbid disorders, with the oppositional defiant disorder (ODD) being one of the most frequently diagnosed comorbid disorders. There is a l...
Source: SafetyLit - August 31, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
On Money, ADHD Diagnosis Can Be Revelatory
After racking up $15,000 in debt, Ellyce Fulmore was diagnosed with A.D.H.D. in December 2020.Credit...Todd Korol for The New York Times A diagnosis of attention deficit hyperactivity disorder in adulthood has solved a mystery for some women, helping them get control over their finances. For Women…#ellycefulmore #adhd #toddkorol #dopamines #edwardmhallowell #hallowelladhdcenters #tiktok #nt #additude
Source: Reuters: Health - August 31, 2023 Category: Consumer Health News Source Type: news
FDA OKs ADHD Generics; Flotation Therapy; Civilians Respond to Distress Calls
(MedPage Today) -- The FDA approved the first generic forms of lisdexamfetamine dimesylate (Vyvanse) capsules and chewables to treat attention deficit-hyperactivity disorder (ADHD) in patients 6 years and older, as well as moderate to severe binge...
Source: MedPage Today Psychiatry - August 30, 2023 Category: Psychiatry Source Type: news
Vaccine Skepticism Spreads to Pets; Generics for ADHD Approved; Malaria in Maryland
(MedPage Today) -- Note that some links may require registration or subscription.
Some dog owners questioned pet vaccines like rabies, survey data showed. (Vaccine)
The FDA approved multiple generics of lisdexamfetamine dimesylate to treat attention...
Source: MedPage Today Pediatrics - August 29, 2023 Category: Pediatrics Source Type: news
Generics of Vyvanse, Takeda's ADHD drug, get FDA green light
Takeda Pharmaceutical Company Limited just lost exclusivity on its ADHD drug.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 28, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
FDA Approves First Generics for Vyvanse
August 28, 2023 -- FDA has approved several first generics of Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets for attention-deficit/hyperactivity disorder (ADHD) in patients six years and older and moderate to severe binge-eating...
Source: Drugs.com - Daily MedNews - August 28, 2023 Category: General Medicine Source Type: news
